UPDATE: Arcutis Biotherapeutics Inc. (ARQT) PT Raised to $46 at Morgan Stanley
Tweet Send to a Friend
(Updated - September 26, 2022 10:03 AM EDT)
Morgan Stanley analyst Vikram Purohit raised the price target on Arcutis ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Morgan Stanley analyst Vikram Purohit raised the price target on Arcutis ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
